Newsroom

Newsroom

The Vanishing Public Company from Private Equity Findings

Events

May 17, 2021
A roundtable discussion with CD&R Operating Partner Roberto Quarta was featured in Private Equity Findings, a publication of the Coller Research Institute produced in collaboration with Professor Josh Lerner of Harvard Business School. The...
Photo of Don Gogel

Media Coverage

May 3, 2021
Private equity has changed significantly in the 30-plus years that Clayton, Dubilier & Rice chairman Donald Gogel has been in the industry but, he explains, the critical ingredients for outperformance remain the same.  
Capco logo

Press Release

April 29, 2021
Clayton, Dubilier & Rice today announced the completion of the previously announced sale of Capco, a global management and technology consultancy, to Wipro Limited (NYSE: WIT). The total purchase price was $1.45 billion.   CD&R funds...
David Novak's picture

Events

April 21, 2021
CD&R Co-President Dave Novak addressed a group of family offices at the Single Family Office Roundtable, hosted by the INSEAD Global Private Equity Initiative and Invest Europe.  His comments focused on the constructive partnership between...
agilon logo

Press Release

April 19, 2021
LONG BEACH, Calif.--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), which partners with primary care physicians to unlock value-based healthcare delivery, announced the closing of its initial public offering of 53,590,000 shares of its common...
Solenis - best managed company.

Press Release

April 13, 2021
WILMINGTON, Del. (USA) – Solenis, a leading global producer of specialty chemicals used in water-intensive industries, is proud to announce it has been selected as a 2021 US Best Managed Company. Sponsored by Deloitte Private and The Wall Street...
HBS New Venture Competition Logo

Press Release

April 1, 2021
The grand prize in the annual Harvard Business School New Venture Competition was awarded to Concord Materials, an integrated materials management platform for construction operators powered by advance tech with a fintech solution, and Hive Health,...
M2GEN Logo Mark

Press Release

March 17, 2021
M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics...
MFG charging stations image.

Press Release

March 15, 2021
MFG, the market leading independent forecourt operator with over 900 sites across Great Britain, is pleased to announce its electric vehicle (“EV”) investment plans.  Through this planned investment MFG will be uniquely positioned to lead the...
S&S Activewear Logo.
Play Video

Press Release

March 12, 2021
Clayton, Dubilier & Rice has completed the previously announced partnership transaction in which CD&R-managed funds invested alongside current owners and management to acquire S&S Activewear, a leading North American distributor of...
PEI Keynote Interview

Media Coverage

March 1, 2022
Strong partnerships are critical to developing businesses at scale throughout key markets in Europe, say Marco Herbst, Greg Laï, Christian Rochat and Eric Rouzier at Clayton, Dubilier & Rice
Call In Podcast Logo.

Media Coverage

February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.